MedTrace Logo

Anticoagulant and Antiarrhythmic Management Based on Continuous Rhythm Monitoring

NCT04038944 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2019-07-31

No results posted yet for this study

Summary

This pilot study aims to assess the feasibility and safety of using an ILR to identify the incidence of recurrent AF after an episode of newly diagnosed AF. The study further aims to assess the risk of AF recurrence in this low risk population based on left atrial and left atrial appendage anatomic and functional indices in addition to the standardized clinical CHA2DS2-Vasc score.

Conditions

  • New Onset Atrial Fibrillation

Sponsors & Collaborators

  • St. Francis Hospital, New York

    lead OTHER

Principal Investigators

  • Joseph Levine, MD · Saint Francis Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-17
Primary Completion
2020-07-31
Completion
2023-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04038944 on ClinicalTrials.gov